Paragon Care WKN: A0Q4D2 ISIN: AU000000PGC4 Kürzel: PXS Branche: Gesundheit, Medizinischer, Vertrieb
Kursdetails
Geld (bid) | 0,1810 (2.545) |
---|---|
Brief (ask/offer) | 0,2080 (2.545) |
Spread | 12,9808 |
Geh. Stück | 0 |
Eröffnung | 0,1950 |
Vortag | 0,1950 |
Tageshoch | 0,1960 |
Tagestief | 0,1935 |
52W Hoch | 0,1990 |
52W Tief | 0,0910 |
Tagesvolumen
in EUR gehandelt | 0 Stk |
---|---|
in AUD gehandelt | 0 Stk |
Gesamt | 0 Stk |
Partner-News
AnzeigeGestern 18:01 Uhr • Partner • Societe Generale
Gestern 16:46 Uhr • Partner • Societe Generale
Gestern 15:42 Uhr • Partner • Societe Generale
Gestern 15:10 Uhr • Partner • onemarkets Blog
Gestern 15:00 Uhr • Partner • BNP Paribas
Aktien-News
Gestern 22:39 Uhr • Artikel • dpa-AFX
Gestern 22:02 Uhr • Artikel • dpa-AFX
Gestern 20:19 Uhr • Artikel • dpa-AFX
Gestern 19:46 Uhr • Partner • shareribs
Geld/Brief Kurse
Neu ladenBörse | Geld | Vol. | Brief | Vol. | Zeit | Vol. ges. | Kurs |
---|---|---|---|---|---|---|---|
L&S Exchange | 0,1810 | 2.545 Stk | 0,2080 | 2.545 Stk | 1713560420 19. Apr | 0,1945 EUR | |
Frankfurt | 0,1800 | 11.667 Stk | 0,2080 | 20.000 Stk | 1713506796 19. Apr | 0,1800 EUR | |
Tradegate | 0,1820 | 5.000 Stk | 0,2080 | 4.000 Stk | 1713558382 19. Apr | 0,1950 EUR | |
Lang & Schwarz | 0,1810 | 2.545 Stk | 0,2080 | 2.545 Stk | 1713560402 19. Apr | 0,1945 EUR | |
TTMzero RT | 1713551927 19. Apr | 0,1950 EUR | |||||
Stuttgart | 0,1820 | 4.444 Stk | 0,2080 | 4.444 Stk | 1713506745 19. Apr | 0,1820 EUR | |
Sydney | 1713420653 18. Apr | 0,3250 AUD | ges. 0 Stk |
Börsennotierung
Marktkapitalisierung in EUR |
---|
128,2 Mio. |
Anzahl der Aktien |
659,3 Mio. |
Termine
28.08.2024 | Quartalsmitteilung |
---|---|
02/25 | Quartalsmitteilung |
Grundlegende Daten zur PARAGON CARE Aktie
Finanzdaten | 2020 | 2021 | 2022 | 2023 | 2024e | 2025e | 2026e |
---|---|---|---|---|---|---|---|
KUV | 0,19 | 0,36 | 0,71 | 0,47 | - | - | - |
Ergebnis je Aktie (bereinigt) | -0,30 | 0,02 | 0,01 | 0,02 | 0,01 | - | - |
Cashflow | 5,3 Mio. | 27,5 Mio. | 19,0 Mio. | 17,7 Mio. | - | - | - |
Eigenkapitalquote | 38,43 % | 41,63 % | 53,79 % | 54,14 % | - | - | - |
Verschuldungsgrad | 160,21 | 140,23 | 83,25 | 80,94 | - | - | - |
EBIT | 4,1 Mio. | 14,0 Mio. | 21,3 Mio. | 26,4 Mio. | - | - | - |
Fundamentaldaten | 2020 | 2021 | 2022 | 2023 | 2024e | 2025e | 2026e |
KCV | 8,50 | 3,05 | 8,51 | 7,00 | - | - | - |
Dividendenrendite | 2,53 % | 4,32 % | 4,02 % | 3,69 % | - | - | - |
Kurs-Gewinn-Verhältnis (KGV) | -0,57 | 12,21 | 25,52 | 10,50 | 29,37 | - | - |
Dividende je Aktie | 0,011 | 0,016 | 0,012 | 0,01 | - | - | - |
Bilanzdaten | 2020 | 2021 | 2022 | 2023 | 2024e | 2025e | 2026e |
Umsatzerlöse | 231,7 Mio. | 235,8 Mio. | 237,6 Mio. | 307,6 Mio. | - | - | - |
Ergebnis vor Steuern | -77,2 Mio. | 12,3 Mio. | 9,9 Mio. | 20,9 Mio. | - | - | - |
Steuern | 66.000 | 4,1 Mio. | 3,3 Mio. | 10,1 Mio. | - | - | - |
Ausschüttungssumme | 7,9 Mio. | 7,9 Mio. | 7,9 Mio. | 7,9 Mio. | - | - | - |
Info PARAGON CARE Aktie
Paragon Care
Paragon Care Limited supplies durable medical equipment, medical devices, and consumable medical products to health and aged care markets in Australia, New Zealand, and internationally. The company offers clinical solutions for anaesthetists, intensivists, cardiac, vascular, and pain management; designs, manufactures, and distributes reagent red blood cells, monoclonal blood grouping reagents, and ancillary products for immunohaematology laboratories; and eye care products, such as ophthalmology and optometry, neonatal vision screening, and procedural kits. It also provides neonatal and paediatric assessment and treatment, including newborn hearing and vision screening, jaundice management, targeted temperature management, cerebral function monitoring, and seizure detection, as well as pain management and enteral feeding solutions; surgical products for hip and knee arthroplasty, infection prevention, pain management, biologics, and the operating room; and equipment repair and maintenance services. In addition, the company offers sterilisable transducers for surgical procedures such as neurology, hepatobiliary, renal, colorectal, vascular, laparoscopic, and robotic procedures; ultrasound systems, shockwave therapy, lasers, and accessories for infection control; and veterinary products, including point-of-care diagnostics, therapeutic lasers, oncology delivery products, centrifuges, autoclaves, IV lines and fluid therapy products, wearable CRI systems, and IT Solutions. Further, it provides telephony, nurse call, access control, CCTV, cordless, and Wi-Fi products. The company was formerly known as Citrofresh International Limited and changed its name to Paragon Care Limited in June 2008. The company was incorporated in 1994 and is based in Mt Waverley, Australia.